Jenburkt Pharmaceuticals standalone net profit rises 4.99% in the June 2025 quarter
Sales rise 9.19% to Rs 35.53 crore
Net profit of Jenburkt Pharmaceuticals rose 4.99% to Rs 7.79 crore in the quarter ended June 2025 as against Rs 7.42 crore during the previous quarter ended June 2024. Sales rose 9.19% to Rs 35.53 crore in the quarter ended June 2025 as against Rs 32.54 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales35.5332.54 9 OPM %25.1928.55 -PBDT10.9010.59 3 PBT10.1810.07 1 NP7.797.42 5Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2025 | 7:37 AM IST